InvestorsHub Logo
Followers 22
Posts 888
Boards Moderated 0
Alias Born 05/09/2012

Re: None

Thursday, 07/30/2020 11:28:55 AM

Thursday, July 30, 2020 11:28:55 AM

Post# of 403217
Per the GMU testing, it seems the research will end in late August per the below PR snip. Hopefully we have news before then but looks like we're about a month out for these testing results:

"As part of this project, Narayanan will first determine the EC50 values, or the concentration of the drug that gives a half-maximal response.

From there, Naryanan and her collaborators will evaluate if Brilacidin has direct virus-killing activity.

They will also assess whether Brilacidin can be provided as a second dose to infected cells without inducing toxicity.

As they work, the researchers will time their experiments to determine the appropriate timing of treatment.

Funding for this research began in May 2020 and will conclude in late August 2020."

insert-text-here
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News